Page 12 - 91307c10 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Harel Insurance Investments & Financial Services Ltd. lessened its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 36.8% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 10,051 shares of the biotechnology company’s stock after selling 5,841 shares during the quarter. Harel Insurance Investments & Financial Services Ltd.’s holdings in […]

Cordatus Wealth Management LLC bought a new stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) during the 2nd quarter, HoldingsChannel reports. The institutional investor bought 1,075 shares of the biotechnology company’s stock, valued at approximately $237,000. Other large investors have also added to or reduced their stakes in the company. Machina Capital […]

Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ten ratings firms that are covering the firm, MarketBeat reports. Two research analysts have rated the stock with a sell rating and eight have assigned a buy rating to the company. The average 1-year […]

New England Research & Management Inc. grew its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 12.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,280 shares of the biotechnology company’s stock after buying an additional […]

Financial Gravity Asset Management Inc. cut its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 19.4% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 224 shares of the biotechnology company’s stock after selling 54 shares during the period. Financial Gravity Asset Management Inc.’s […]